Cargando…
Pilot study of genome-wide DNA methylation and gene expression for treatment response to escitalopram in panic disorder
BACKGROUND: Antidepressants, particularly selective serotonin reuptake inhibitors, are currently considered the first-line treatment for panic disorder (PD). However, little is known about the relationship between the biomarkers that may predict better treatment. AIM: To compare genome-wide methylat...
Autores principales: | Zou, Zhi-Li, Zhang, Yuan, Huang, Yu-Lan, Wang, Jin-Yu, Zhou, Bo, Chen, Hua-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494772/ https://www.ncbi.nlm.nih.gov/pubmed/37701547 http://dx.doi.org/10.5498/wjp.v13.i8.524 |
Ejemplares similares
-
The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007) -
Glutamate decarboxylase 1 gene polymorphisms are associated with respiratory symptoms in panic disorder
por: Zou, Zhi-Li, et al.
Publicado: (2023) -
Epigenome-wide association study of DNA methylation in panic disorder
por: Shimada-Sugimoto, Mihoko, et al.
Publicado: (2017) -
Identification and characterization of noncoding RNAs-associated competing endogenous RNA networks in major depressive disorder
por: Zou, Zhi-Li, et al.
Publicado: (2023) -
“DNA Methylation signatures in panic disorder”
por: Iurato, Stella, et al.
Publicado: (2017)